Tango Therapeutics Inc (TNGX)
$23.34 -$4.56 (-16.33%) 10:35 PM 10/23/2026
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$3.72B -
Day's Range
$22.68 - $25.94 -
Volume
5,025,405 -
52 Week Low / High
$6.69 - $34.39 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyst ratings: Buy 11, Hold 1, Sell 0.
Company News
-
Tango Therapeutics Just Improved On This 'Unprecedented' Cancer Drug — Oct 23, 2026
Tango Therapeutics beat expectations Friday for its combination using Revolution Medicines' newly approved drug in pancreatic cancer....
-
Tango Therapeutics stock falls despite positive cancer trial data — Oct 23, 2026
Investing.com -- Tango Therapeutics (NASDAQ:TNGX) shares fell 6% Friday following the company's presentation of Phase 1/2 study results for vopimetostat and daraxonrasib in pancreatic cancer, despite what the company characterized as promising data. Still guessing which stocks will beat th...
-
William Blair Expands Biotech Research as Veteran Analyst Alethia Young Initiates Coverage — Oct 21, 2026
CHICAGO, October 21, 2026--(BUSINESS WIRE)--William Blair today announced that Alethia Young has initiated coverage of 13 biotechnology companies, marking the next step in the firm's continued expansion of its biotech offering. Young joined William Blair in May 2026 as part of a broader in...
Portfolio
Comprised of 1 portfolios